{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:08:28Z","timestamp":1787620108570,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-025-01636-0","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:33:30Z","timestamp":1760448810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Temporal trend and individual and hospital characteristics associated to vancomycin-resistant Enterococcus faecium bloodstream infections: a retrospective analysis from the national surveillance system, Italy 2015\u20132023"],"prefix":"10.1186","volume":"14","author":[{"given":"Chiara","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Iacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Isonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Iera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Del","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"D\u2019Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Pezzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1636_CR1","unstructured":"World Health Organization. Ten threats to global health in 2019. https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019. Accessed 17 Mar 2025."},{"key":"1636_CR2","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"12","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903\u201310. https:\/\/doi.org\/10.2147\/IDR.S234610.","journal-title":"Infect Drug Resist"},{"issue":"7","key":"1636_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309\u201318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030.","journal-title":"Pathog Glob Health"},{"issue":"10459","key":"1636_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1.","journal-title":"Lancet"},{"key":"1636_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jgar.2018.08.016","volume":"16","author":"T Lee","year":"2019","unstructured":"Lee T, Pang S, Abraham S, Coombs GW, Liu Y, Kalimuddin S, et al. Antimicrobial-resistant CC17 Enterococcus faecium: the past, the present and the future. J Glob Antimicrob Resist. 2019;16:36\u201347. https:\/\/doi.org\/10.1016\/j.jgar.2018.08.016.","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"1636_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200003093421007","volume":"342","author":"BE Murray","year":"2000","unstructured":"Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710\u201321. https:\/\/doi.org\/10.1056\/NEJM200003093421007.","journal-title":"N Engl J Med"},{"key":"1636_CR7","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:82532","volume-title":"Antibiotic resistance threats in the united states, 2019","author":"Centers for Disease Control and Prevention","year":"2019","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the united states, 2019. Atlanta (GA): CDC; 2019."},{"key":"1636_CR8","volume-title":"Bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: WHO; 2024."},{"issue":"4","key":"1636_CR9","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.1128\/mBio.00534-13","volume":"4","author":"F Lebreton","year":"2013","unstructured":"Lebreton F, van Schaik W, Manson McGuire A, Gilmore MS, Bonomo RA, Earl AM, et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. mBio. 2013;4(4):e00534\u201313. https:\/\/doi.org\/10.1128\/mBio.00534-13.","journal-title":"mBio"},{"issue":"4","key":"1636_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias CA, Murray BE. The rise of the enterococcus: beyond Vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266\u201378. https:\/\/doi.org\/10.1038\/nrmicro2761.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"1636_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1128\/mBio.00534-13","volume":"37","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Webb AK, Limbago B, Kallen AJ, Walters MS, Dudeck MA, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011\u20132014. Infect Control Hosp Epidemiol. 2016;37(11):1288\u2013301. https:\/\/doi.org\/10.1128\/mBio.00534-13.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"1636_CR12","doi-asserted-by":"publisher","first-page":"e01978","DOI":"10.1128\/AAC.01978-18","volume":"63","author":"J Liese","year":"2019","unstructured":"Liese J, Sch\u00fcle L, Oberhettinger P, Tsch\u00f6rner L, Nguyen T, D\u00f6rfel D, et al. Expansion of vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole-genome-based outbreak investigation. Antimicrob Agents Chemother. 2019;63(5):e01978\u201318. https:\/\/doi.org\/10.1128\/AAC.01978-18. PMID: 30782988; PMCID: PMC6496047.","journal-title":"Antimicrob Agents Chemother"},{"key":"1636_CR13","volume-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual epidemiological report 2023","author":"European Centre for Disease Prevention and Control","year":"2024","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual epidemiological report 2023. Stockholm: ECDC; 2024."},{"key":"1636_CR14","unstructured":"World Health Organization Regional Office for Europe. AMR Dashboard, Copenhagen WHO, Europe. https:\/\/worldhealthorg.shinyapps.io\/WHO-AMR-Dromaniashboard\/. Accessed 17 Mar 2025."},{"key":"1636_CR15","volume-title":"E Il gruppo Di lavoro AR-ISS. AR-ISS: Sorveglianza nazionalE dell\u2019Antibiotico-Resistenza. Dati 2023","author":"S Iacchini","year":"2024","unstructured":"Iacchini S, Boros S, Pezzotti P, Errico G, Del Grosso M, Camilli R, Giufr\u00e8 M, Pantosti A, Maraglino F, Palamara AT, D\u2019Ancona F, Monaco M. E Il gruppo Di lavoro AR-ISS. AR-ISS: Sorveglianza nazionalE dell\u2019Antibiotico-Resistenza. Dati 2023. Roma: Istituto Superiore di Sanit\u00e0; 2024."},{"key":"1636_CR16","unstructured":"Ministero della Salute. Principali evidenze sull\u2019attivit\u00e0 di ricovero ospedaliero. Anno 2023. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_3294_allegato.pdf. Accessed 17 Mar 2025."},{"key":"1636_CR17","unstructured":"Ministero della Salute. Rapporto sulla resistenza antimicrobica in Italia. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_3294_allegato.pdf Accessed 17 Mar 2025."},{"key":"1636_CR18","unstructured":"Italy, Decree of the President of the Council of Ministers, March. 3, 2017. Definition and update of the essential levels of care (LEA). Official Gazette of the Italian Republic - General Series, no. 65; 2017. https:\/\/www.gazzettaufficiale.it\/eli\/id\/2017\/03\/18\/17A02015\/sg. Accessed 17 Mar 2025."},{"key":"1636_CR19","unstructured":"World Health Organization. WHONET: software for antimicrobial resistance surveillance. https:\/\/whonet.org. Accessed 17 Mar 2025."},{"key":"1636_CR20","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of mics and zone diameters. http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 17 Mar 2025."},{"key":"1636_CR21","unstructured":"Eurostat NUTS. Nomenclature of territorial units for statistics. Luxembourg: Eurostat. [Accessed: 16 Apr 2025]. Available from: https:\/\/ec.europa.eu\/eurostat\/web\/nuts\/background"},{"key":"1636_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2288-3-21","volume":"3","author":"AJD Barros","year":"2003","unstructured":"Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21\u201333. https:\/\/doi.org\/10.1186\/1471-2288-3-21.","journal-title":"BMC Med Res Methodol"},{"key":"1636_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2288-8-80","volume":"8","author":"CA Santos","year":"2008","unstructured":"Santos CA, Fiaccone RL, Oliveira NF, Cunha S, Barreto ML, do Carmo MB, Moncayo AL, Rodrigues LC, Cooper PJ, Amorim LD. Estimating adjusted prevalence ratio in clustered cross-sectional epidemiological data. BMC Med Res Methodol. 2008;8:80. https:\/\/doi.org\/10.1186\/1471-2288-8-80. PMID: 19087281; PMCID: PMC2625349.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"1636_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.51847\/6fNKoyVIsM","volume":"12","author":"S Stolfa","year":"2021","unstructured":"Stolfa S, Romanelli F, Ronga L, Del Prete R, Mosca A. The increase of vancomycin-resistant Enterococcus faecium in urine: a retrospective study at university hospital of Bari. Pharmacophore. 2021;12(5):11\u20139. https:\/\/doi.org\/10.51847\/6fNKoyVIsM.","journal-title":"Pharmacophore"},{"key":"1636_CR25","doi-asserted-by":"publisher","unstructured":"Bressan R, Knezevich A, Monticelli J, Campanile F, Busetti M, Santagati M, Dolzani L, Milan A, Bongiorno D, Di Santolo M, Tonin EA, Stefani S, Luzzati R, Lagatolla C. Spread of Vancomycin-Resistant Enterococcus faecium Isolates Despite Validated Infection Control Measures in an Italian Hospital: Antibiotic Resistance and Genotypic Characterization of the Endemic Strain. Microb Drug Resist. 2018;24(8):1148\u20131155. https:\/\/doi.org\/10.1089\/mdr.2017.0314. Epub 2018 Jan 26. PMID: 29373085.","DOI":"10.1089\/mdr.2017.0314"},{"issue":"4","key":"1636_CR26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s42770-020-00360-8","volume":"51","author":"S Fioriti","year":"2020","unstructured":"Fioriti S, Simoni S, Caucci S, Morroni G, Ponzio E, Coccitto SN, Brescini L, Cirioni O, Menzo S, Biavasco F, Giovanetti E, Brenciani A, Vignaroli C. Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018. Braz J Microbiol. 2020;51(4):1607\u201313. https:\/\/doi.org\/10.1007\/s42770-020-00360-8. Epub 2020 Aug 11. PMID: 32783169; PMCID: PMC7688800.","journal-title":"Braz J Microbiol"},{"key":"1636_CR27","volume-title":"National report on antibiotics use in Italy. Year 2023","author":"The Medicines Utilisation Monitoring Centre","year":"2025","unstructured":"The Medicines Utilisation Monitoring Centre. National report on antibiotics use in Italy. Year 2023. Rome: Italian Medicines Agency; 2025. Rapporto AIFA 2025 sugli antibiotici."},{"key":"1636_CR28","volume-title":"National report on antibiotics use in Italy. Year 2022","author":"The Medicines Utilisation Monitoring Centre","year":"2025","unstructured":"The Medicines Utilisation Monitoring Centre. National report on antibiotics use in Italy. Year 2022. Rome: Italian Medicines Agency; 2025. Rapporto AIFA 2024 sugli antibiotici."},{"key":"1636_CR29","volume-title":"National report on antibiotics use in Italy. Year 2021","author":"The Medicines Utilisation Monitoring Centre","year":"2025","unstructured":"The Medicines Utilisation Monitoring Centre. National report on antibiotics use in Italy. Year 2021. Rome: Italian Medicines Agency; 2025. Rapporto AIFA 2023 sugli antibiotici."},{"key":"1636_CR30","volume-title":"National report on antibiotics use in Italy. Year 2020","author":"The Medicines Utilisation Monitoring Centre","year":"2025","unstructured":"The Medicines Utilisation Monitoring Centre. National report on antibiotics use in Italy. Year 2020. Rome: Italian Medicines Agency; 2025. Rapporto AIFA 2022 sugli antibiotici."},{"key":"1636_CR31","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1086\/666331","volume":"33","author":"JA McKinnell","year":"2012","unstructured":"McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA, et al. Association between vancomycin-resistant enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol. 2012;33:718\u201324.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1636_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13756-015-0064-5","volume":"4","author":"C Forstner","year":"2015","unstructured":"Forstner C, Diab-Elschahawi M, Kivaranovic D, Graninger W, Mitteregger D, Macher M, Wrba T, Presterl E. Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting. Antimicrob Resist Infect Control. 2015;4:25. https:\/\/doi.org\/10.1186\/s13756-015-0064-5. PMID: 26078865; PMCID: PMC4466807.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"1636_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/antibiotics14050522","volume":"14","author":"DE Radford-Smith","year":"2025","unstructured":"Radford-Smith DE, Anthony DC. Vancomycin-Resistant E. faecium: addressing global and clinical challenges. Antibiotics. 2025;14(5):522.","journal-title":"Antibiotics"},{"issue":"8","key":"1636_CR34","doi-asserted-by":"publisher","first-page":"fnv012","DOI":"10.1093\/femsle\/fnv012","volume":"362","author":"L Crouzet","year":"2015","unstructured":"Crouzet L, Rigottier-Gois L, Serror P. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci. FEMS Microbiol Lett. 2015;362(8):fnv012.","journal-title":"FEMS Microbiol Lett"},{"key":"1636_CR35","unstructured":"European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/infectious-disease-topics\/related-public-health-topics\/antimicrobial-resistance\/directory-guidance Accessed 17 Mar 2025."},{"key":"1636_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jgar.2025.01.016","volume":"41","author":"AC Almeida-Santos","year":"2025","unstructured":"Almeida-Santos AC, Novais C, Peixe L, Freitas AR. Vancomycin-resistant Enterococcus faecium: a current perspective on resilience, adaptation, and the urgent need for novel strategies. J Glob Antimicrob Resist. 2025;41:233\u201352. https:\/\/doi.org\/10.1016\/j.jgar.2025.01.016. Epub 2025 Jan 27. PMID: 39880121.","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"1636_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1086\/501806","volume":"21","author":"PS Falk","year":"2000","unstructured":"Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol. 2000;21(9):575\u201382.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"1636_CR38","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1086\/676864","volume":"35","author":"R Kaki","year":"2014","unstructured":"Kaki R, Yu Y, O\u2019Neill C, Lee C, Mertz D. Vancomycin-resistant Enterococcus (VRE) transmission and risk factors in contacts of VRE carriers. Infect Control Hosp Epidemiol. 2014;35(7):876\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1636_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1469-0691.2008.02074.x","volume":"14","author":"JP Marcel","year":"2008","unstructured":"Marcel JP, Alfa M, Baquero F, Etienne J, Goossens H, Harbarth S, et al. Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect. 2008;14:895\u2013907.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1636_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/cid\/ciw872","volume":"64","author":"KE Raven","year":"2017","unstructured":"Raven KE, Gouliouris T, Brodrick H, Coll F, Brown NM, Reynolds R, Reuter S, T\u00f6r\u00f6k ME, Parkhill J, Peacock SJ. Complex routes of nosocomial vancomycin-resistant Enterococcus faecium transmission revealed by genome sequencing. Clin Infect Dis. 2017;64(7):886\u201393. https:\/\/doi.org\/10.1093\/cid\/ciw872. PMID: 28362945; PMCID: PMC5439346.","journal-title":"Clin Infect Dis"},{"key":"1636_CR41","unstructured":"Humphreys H, Werner G, Coque TM, Hammerum AM et al. Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile? J Hosp Infect. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13:1\u201311."},{"key":"1636_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/ese.13.47.19046-en","volume":"13","author":"G Werner","year":"2008","unstructured":"Werner G, Coque TM, Hammerum AM, et al. Emergence and spread of Vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13:1\u201311.","journal-title":"Euro Surveill"},{"issue":"2","key":"1636_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1532\/IJH97.E0632","volume":"86","author":"M Schmidt-Hieber","year":"2007","unstructured":"Schmidt-Hieber M, Blau IW, Schwartz S, Uharek L, Weist K, Eckmanns T, et al. Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. Int J Hematol. 2007;86(2):158\u201362.","journal-title":"Int J Hematol"},{"issue":"4","key":"1636_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkm270","volume":"60","author":"A Deplano","year":"2007","unstructured":"Deplano A, Denis O, Nonhoff C, Rost F, Byl B, Jacobs F, et al. Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control. J Antimicrob Chemother. 2007;60(4):849\u201354.","journal-title":"J Antimicrob Chemother"},{"key":"1636_CR45","doi-asserted-by":"publisher","first-page":"1041668","DOI":"10.3389\/fmed.2022.1041668","volume":"9","author":"M Monaco","year":"2022","unstructured":"Monaco M, Floridia M, Giuliano M, Palmieri L, Lo Noce C, Pantosti A, Palamara AT, Brusaferro S, Onder G, Italian National Institute of Health COVID-19 Mortality Group. Hospital-acquired bloodstream infections in patients deceased with COVID-19 in Italy (2020\u20132021). Front Med (Lausanne). 2022;9:1041668. https:\/\/doi.org\/10.3389\/fmed.2022.1041668. PMID: 36465906; PMCID: PMC9713028.","journal-title":"Front Med (Lausanne)"},{"key":"1636_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13756-022-01113-y","volume":"11","author":"M Floridia","year":"2022","unstructured":"Floridia M, Giuliano M, Monaco M, et al. Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020\u20132021. Antimicrob Resist Infect Control. 2022;11:74. https:\/\/doi.org\/10.1186\/s13756-022-01113-y.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1636_CR47","volume-title":"COVID-19: U.S. Impact on antimicrobial resistance, special report 2022","author":"CDC","year":"2022","unstructured":"CDC. COVID-19: U.S. Impact on antimicrobial resistance, special report 2022. Atlanta, GA: U.S. Department of Health and Human Services; 2022."},{"key":"1636_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13756-019-0594-3","volume":"8","author":"R Markwart","year":"2019","unstructured":"Markwart R, Willrich N, Haller S, Noll I, Koppe U, Werner G, Eckmanns T, Reuss A. The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German antimicrobial resistance surveillance (ARS). Antimicrob Resist Infect Control. 2019;8:147. https:\/\/doi.org\/10.1186\/s13756-019-0594-3. PMID: 31485325; PMCID: PMC6712849.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"1636_CR49","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","volume":"9","author":"O Ayobami","year":"2020","unstructured":"Ayobami O, Willrich N, Reuss A, Eckmanns T, Markwart R. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microbes Infect. 2020;9(1):1180\u201393. PMID: 32498615; PMCID: PMC7448851.","journal-title":"Emerg Microbes Infect"},{"key":"1636_CR50","doi-asserted-by":"publisher","unstructured":"Simner PJ, Adam H, Baxter M, McCracken M, Golding G, Karlowsky JA, Nichol K, Lagac\u00e9-Wiens P, Gilmour MW; Canadian Antimicrobial Resistance Alliance (CARA);, Hoban DJ, Zhanel GG. Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013). Antimicrob Agents Chemother. 2015;59(7):4315-7. https:\/\/doi.org\/10.1128\/AAC.00384-15. Epub 2015 Apr 20. PMID: 25896693; PMCID: PMC4468682.","DOI":"10.1128\/AAC.00384-15"},{"issue":"3","key":"1636_CR51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1590\/S1517-838246320140403","volume":"46","author":"D Moemen","year":"2015","unstructured":"Moemen D, Tawfeek D, Badawy W. Healthcare-associated Vancomycin resistant Enterococcus faecium infections in the Mansoura university hospitals intensive care units, Egypt. Braz J Microbiol. 2015;46(3):777\u201383. PMID: 26413060; PMCID: PMC4568866.","journal-title":"Braz J Microbiol"},{"key":"1636_CR52","doi-asserted-by":"publisher","unstructured":"Tripathi A, Shukla SK, Singh A, Prasad KN. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India. Indian J Med Microbiol. 2016 Jan-Mar;34(1):38\u201345. https:\/\/doi.org\/10.4103\/0255-0857.174099. PMID: 26776117.","DOI":"10.4103\/0255-0857.174099"},{"key":"1636_CR53","doi-asserted-by":"publisher","unstructured":"Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26(5):1127-33. https:\/\/doi.org\/10.1086\/520311. PMID: 9597241.","DOI":"10.1086\/520311"},{"issue":"11","key":"1636_CR54","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1086\/522678","volume":"28","author":"C Buke","year":"2007","unstructured":"Buke C, Armand-Lefevre L, Lolom I, Guerinot W, Deblangy C, Ruimy R, Andremont A, Lucet JC. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays. Infect Control Hosp Epidemiol. 2007;28(11):1255\u201360. https:\/\/doi.org\/10.1086\/522678. Epub 2007 Sep 28. PMID: 17926276.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1636_CR55","unstructured":"Nelson I, Agudelo Higuita MMH. Enterococcal disease, epidemiology, and implications for treatment. In: Enterococci: from commensals to leading causes of drug resistant infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK190429\/"},{"key":"1636_CR56","doi-asserted-by":"publisher","unstructured":"Curtis J, Donskey. The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial Pathogens, Clinical Infectious Diseases, Volume 39, Issue 2, 15 July 2004, Pages 219\u2013226. https:\/\/doi.org\/10.1086\/422002","DOI":"10.1086\/422002"},{"key":"1636_CR57","doi-asserted-by":"crossref","unstructured":"Liu, X., Long, Y., Greenhalgh, C., Steeg, S., Wilkinson, J., Li, H., Spencer, A.(2023). A systematic review and meta-analysis of risk factors associated with healthcare-associated infections among hospitalized patients in Chinese general hospitals from 2001 to2022.Journal of Hospital Infection, 135, 37\u201349.","DOI":"10.1016\/j.jhin.2023.02.013"},{"key":"1636_CR58","doi-asserted-by":"crossref","unstructured":"Gu GY, Chen M, Pan JC, Xiong XL. Risk of multi-drug-resistant organism acquisition from prior bed occupants in the intensive care unit: a meta-analysis. J Hosp Infect. 2023;139:44\u201355. doi: 10.1016\/j.jhin.2023.06.020. Epub 2023 Jul 3. PMID: 37406860.","DOI":"10.1016\/j.jhin.2023.06.020"},{"key":"1636_CR59","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12879-024-09487-7","volume":"24","author":"A Antonelli","year":"2024","unstructured":"Antonelli A, Ales ME, Chiecca G, et al. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in lombardy, Italy, in 2022. BMC Infect Dis. 2024;24:632. https:\/\/doi.org\/10.1186\/s12879-024-09487-7.","journal-title":"BMC Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01636-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01636-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01636-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T01:05:48Z","timestamp":1760490348000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01636-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01636-0","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study only includes anonymised routine surveillance data. Ethical approval for analysis of such surveillance data is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript and gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}